Disclosures for "Convergent Causal Mapping of Memory and a Brain Stimulation Target for Memory Dysfunction"
-
Dr. Howard has received intellectual property interests from a discovery or technology relating to health care. Dr. Howard has a non-compensated relationship as a Founder with KiTH Solutions that is relevant to AAN interests or activities.
-
Dr. Kwon has nothing to disclose.
-
Mr. Madan has nothing to disclose.
-
Mr. Garimella has nothing to disclose.
-
Dr. Schaper has nothing to disclose.
-
The institution of Dr. Kletenik has received research support from NIH.
-
The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Canada. Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Ng has received research support from Eisai. The institution of Dr. Ng has received research support from Paladin Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
-
Dr. Mosley has nothing to disclose.
-
Dr. Grafman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Grafman has received research support from NIH. Dr. Grafman has received publishing royalties from a publication relating to health care.
-
Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
-
The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
-
Author has nothing to disclose
-
Prof. Johnson has nothing to disclose.
-
Author has nothing to disclose
-
Constantine Lyketsos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Avanir, Karuna, Maplight, Axsome, GW Research Limited, Merck, EXCIVA GmbH, Otsuka, IntraCellular Therapies, Medesis, BMS, IQVIA. Constantine Lyketsos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. The institution of Constantine Lyketsos has received research support from NIA. Constantine Lyketsos has received publishing royalties from a publication relating to health care. Constantine Lyketsos has received publishing royalties from a publication relating to health care.
-
Mae Morton-Dutton has nothing to disclose.
-
Dr. Giftakis has stock in Medtronic. Dr. Giftakis has received intellectual property interests from a discovery or technology relating to health care.
-
Author has nothing to disclose
-
Dr. Rouhl has nothing to disclose.
-
Dr. Ko has nothing to disclose.
-
Mrs. Schmahl has nothing to disclose.
-
The institution of Dr. Baldermann has received research support from Else Kröner-Fresenius-Stiftung.
-
Dr. Andrade has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Corbetta has nothing to disclose.
-
Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epi-Minder Study, Australia (Mark Cook, PI). Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for START study (Hal Blumenfeld, PI). Dr. Fisher has stock in Avails Medical stock options (drug level testing). Dr. Fisher has stock in Eysz stock options (eye-movement seizure detection). Dr. Fisher has stock in Irody stock options (health records databases). Dr. Fisher has stock in Smart-Monitor stock options (shake-detector watch). Dr. Fisher has stock in Zeto stock options, dry, wireless EEG. The institution of Dr. Fisher has received research support from NaviFUS (focused ultrasound).
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Prof. Hermiller has nothing to disclose.
-
The institution of Prof. Voss has received research support from National Institutes of Health. Prof. Voss has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with National Institutes of Health.
-
Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
-
Prof. Kahana has stock in Nia Therapeutics. Prof. Kahana has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Mrs. Smith has received research support from Sorridi Therapeutics.
-
Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
-
Dr. Siddiqi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Magnus Medical. Dr. Siddiqi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brainsway Ltd. Dr. Siddiqi has stock in Brainsway Ltd. Dr. Siddiqi has stock in Magnus Medical. Dr. Siddiqi has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Horn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
-
Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.